Hemogenyx Pharmaceuticals PLC Announces Clinical Trial Update... (ACCESS Newswire) - Oct 29, 2025 - "Hemogenyx Pharmaceuticals plc...is pleased to announce that the independent Data Safety Monitoring Board ('DSMB') overseeing the Company's ongoing Phase I clinical trial of HG-CT-1...has reviewed safety data from the first three patients treated at the initial dose level and has recommended continuation of the trial with escalation to the next dose level....The trial will now proceed to the next planned dose cohort in accordance with the FDA-approved clinical protocol."
DSMB • Trial status • Acute Myelogenous Leukemia
|